Celemics Appoints Two New Outside Directors and Sees Two Resignations, Outside Director Ratio Maintained at 40%

Celemics appointed Lim Geon-myeon, professor emeritus at Sungkyunkwan University, and Choi Seok-mun, research director at Medigard, as new outside directors effective July 13, 2026.
Existing outside directors Cha Jeong-jun and Kim Eun-mi resigned on July 10, 2026 for personal reasons.
Total registered directors increased from 8 to 10, but the number of outside directors remained at 4, lowering the outside director ratio from 50% to 40%.
The new outside directors bring expertise in law and technology management, expected to strengthen board independence.
This report does not include any capital changes or direct impact on shareholder value.
[AI Summary]Celemics outside director change is a board restructuring with no capital dilution, limiting short-term stock price impact. The expertise of new directors may improve long-term governance, but the reduced outside director ratio warrants monitoring for minority shareholder protection.